BALPHARMA.BOBALPHARMA.BOBSE
Loading
Enterprise value to sales ratio
3Y CAGR
-1.5%/yr
vs -2.9%/yr prior
5Y CAGR
-1.3%/yr
Consistent
Acceleration
+1.4pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.90 | +8.1% |
| 2024 | 0.83 | +7.1% |
| 2023 | 0.78 | -17.5% |
| 2022 | 0.94 | +24.5% |
| 2021 | 0.76 | -21.3% |
| 2020 | 0.96 | -2.3% |
| 2019 | 0.99 | -7.3% |
| 2018 | 1.06 | +14.7% |
| 2017 | 0.93 | -12.7% |
| 2016 | 1.06 | - |